摘要
BackgroudThere were limitations existing in programmed cell-death ligand 1 (PD-L1) as predictive biomarkers for breast cancer (BC), hence exploring the correlation between PD-L1 levels and other biomarkers in BC may become a very useful therapeutic clinical tool. @@@ MethodsA total of 301 Chinese patients with different BC subtypes including 47 HR+/HER2+, 185 HR+/HER2-, 38 HR-/HER2+, and 31 triple-negative breast cancer (TNBC) were enrolled in our study. Next-generation sequencing based Yuansu450 gene panel was used for genomic alteration identification and PD-L1 expression was tested using immunohistochemistry. @@@ ResultsThe most prevalent BC-related mutations were TP53 mutations, followed by mutations in PIK3CA, ERBB2, CDK12, and GATA3 in our Chinese cohort. We found that mutations DDR2 and MYCL were only mutated in HR-/HER2+ subtype, whereas H3-3A and NRAS mutations were only occurred in HR-/HER2- subtype. The percentage of patients with PD-L1-positive expression was higher in patients with HR-/HER2- mainly due to the percentage of PD-L1-high level. Mutational frequencies of TP53, MYC, FAT4, PBRM1, PREX2 were observed to have significant differences among patients with different BC subtypes based on PD-L1 levels. Moreover, a positive correlation was observed between TMB and PD-L1 level in HR+/HER2- subtype, and showed that the proportion of patients with high PD-L1 expression was higher than that of patients with low PD-L1 expression in the HR+/HER2- and HR+/HER2+ cohorts with high Ki67 expression. @@@ ConclusionsThe genomic alterations based on PD-L1 and other biomarkers of different cohorts may provide more possibilities for the treatment of BC with different subtypes.
学科与关键词
- Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung CancerLi, Yue; Li, Chong; Jiang, Ya; Han, Xue; Liu, Sisi; Xu, Xiuxiu; Tang, Wanxiangfu; Ou, Qiuxiang; Bao, Hua; Wu, Xue; Shao, Yang; Xing, Minyan; Zhang, Yixiang*; Wang, Yuezhen*Journal of Oncology, 2022, 2022: 1763778.被引 1
- Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patientsLi, Kang; Liu, Jun; Wu, Lin; Xiao, Yajie; Li, Jia; Du, Haijian; Zhao, Zhikun; Sun, Chao; Zhao, Yongtian; Yang, Jie; Wu, Dongfang; Zhao, Zhuxiang*; Chen, Bolin*Cancer Cell International, 2022, 22(1): 138.被引 7
- Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 statusZhang, Guochun; Ren, Chongyang; Li, Cheukfai; Wang, Yulei; Chen, Bo; Wen, Lingzhu; Jia, Minghan; Li, Kai; Mok, Hsiaopei; Cao, Li; Chen, Xiaoqing; Lin, Jiali; Wei, Guangnan; Li, Yingzhi; Zhang, Yuchen; Balch, Charles M.; Liao, Ning*BMC Medicine, 2022, 20(1): 142.被引 47
